On the heels of FDA approval of its new anti-spasticity drug Gablofen, CNS Therapeutics has raised $3 million in equity, according to documents filed with the Securities and Exchange Commission.

Drug companies are rare in medical-device crazed Minnesota. Even more rare is a startup that can win approval from the Food and Drug Administration, given the cost and regulatory hurdles of pushing drugs to market, these days.So it’s heartening to see the FDA approval of Gablofen (who thinks of these names anyway?), a movement disorder [...]

CVRx Inc. in Plymouth, Minn. said Monday that hypertension patients using its Rheos stimulation device reported a sharp drop in blood pressure after four years.In a study presented to the European Society of Hypertension meeting, the company said patients’ average systolic blood pressure dropped 27 percent to 140 mmHg (millimeters of mercury) from 193 mmHg [...]

Previous investors InterWest Partners and Thomas McNerney Partners led the round. The company raised $6 million last year, according to filing with the Securities and Exchange Commission.

Autonomic is creating a small, implantable medical device to treat severe headaches, according to a news release from InterWest. It was created in 2007 through research by Clinic neurologist Dr. Ali Rezai, who remains on the company’s board.

The autoimmune drug-maker Lycera will fund testing on two of its drugs. One drug will go through Phase II proof-of-concept studies while another will move into Phase I clinical trials, according to the release.